Ighovwerha Ofotokun MD MSc

PubMed

• 1 citations
  Combined Sequential Antiretroviral Therapy-Induced Immune Reconstitution Bone Loss and Estrogen Deficiency Bone Loss Are Cumulative in Mice Models.
  Sadaf Dabeer, Ashish Kumar Tripathi, Daiana Weiss, Tatyana Vikulina, Ighovwerha Ofotokun
  The Journal of Infectious Diseases. 2025-04-15
• Efficacy and Durability of Immune Response After Receipt of Hepatitis A Vaccine in People With Human Immunodeficiency Virus.
  Bahaa Kazzi, Amal Naji, Serena Maria Dib, Lana Khalil, Sonia Tandon Wimalasana
  Open Forum Infectious Diseases. 2025-04-01
• Brief Report: The Implications of Removing Race From Interpretation of Pulmonary Function Among Persons With or Without HIV.
  Richard J Wang, Ken M Kunisaki, Alison Morris, M Bradley Drummond, Mehdi Nouraie
  Journal of Acquired Immune Deficiency Syndromes. 2025-04-01

Journal Articles

• Longitudinal Associations Between Food Insecurity and Substance Use in a Cohort of Women with or at Risk for HIV in the United States  
  Daniel Merenstein, Ighovwerha Ofotokun, Sheri D Weiser, Adaora A Adimora, Addiction
• Food Insecurity, Internalized Stigma, and Depressive Symptoms Among Women Living with HIV in the United States  
  Adaora A Adimora, Sheri D Weiser, Daniel Merenstein, Mardge H Cohen, Ighovwerha Ofotokun, Phyllis C Tien, AIDS and Behavior
• HIV Transmission Risk Behavior in a Cohort of HIV-infected TreatmentNaïve Men and Women in the United States  
  Landovitz RJ, Tran TT, Cohn SE, Ofotokun I, Godfrey C, Kuritzkes DR, Lennox JL, Currier JS, Ribaudo HJ, AIDS Behav, 1/16/2016
• Future Desire for Children Among Women Living with HIV in Atlanta, Georgia  
  Haddad LB, Machen LK, Cordes S, Huylebroeck B, Delaney A, Ofotokun I, Nguyen ML, Jamieson DJ, AIDS Care, 1/1/2015
• Contraceptive Methods and Risk of HIV Acquisition or Female-to-Male Transmission  
  Haddad LB, Polis CB, Sheth AN, Brown J, Kourtis AP, King C, Chakraborty R, Ofotokun I, Curr HIV/AIDS Rep, 1/9/2014
• Metabolic and bone disorders in people with HIV: What we know from low and middleincome countries  
  Ali MK, Magee MJ, Jones TK, Tungsiripat M, Ofotokun I, Levitt NS, Rimland D, Armstrong WS, J Acquir Immune Defic Syndr, 1/1/2014
• Pharmacokinetic enhancers in HIV therapeutics  
  Larson KB, Wang K, Delille C, Ofotokun I, and Acosta EP, Clin Pharmacokinet, 1/1/2014
• Tenofovir and Emtricitabine Uptake into Non-Monocytic Female Genital Tract Cells with and without Hormonal Contraceptives  
  James AM, King KR, Ofotokun I, Sheth AN, Acosta EP, Journal of Experimental Pharmacology, 1/1/2013
• Tenofovir: Once-daily Dosage in the Management of HIV Infection  
  James AM, Ofotokun I, Sheth AN, Acosta EP, King KR, Clinical Medicine Insights: Therapeutics, 1/1/2012
• Workshop Pharmacogenomics-A Path Towards Personalized HIV Care  
  Haas DW, Kuritzkes DR, Ritchie MD, Amur S, Gage BF, Maartens G, Masys D, Fellay J, Phillips E, Ribaudo HJ, Freedberg KA, Petropoulos C, Manolio TA, Gulick RM, Haubrich..., HIV Clin Trials, 1/1/2011
• Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the Cterminus of HIV-1 reverse transcriptase  
  Brehm JH, Lalama CM, Hughes MD, Haubrich R, Riddler SA, Sluis-Cremer N, Mellors JW; AIDS Clinical Trials Group Study A5142 Protocol Team, J Acquir Immune Defic Syndr, 1/1/2011
• Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229  
  McComsey GA, Walker UA, Budhathoki CB, Su Z, Currier JS, Kosmiski L, Naini LG, Charles S, Medvik K, Aberg JA; AIDS Clinical Trials Group A5229 Team, AIDS, 1/1/2010
• Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment  
  Haubrich RH, Riddler SA, DiRienzo AG, Komarow L, Powderly WG, Klingman K, Garren KW, Butcher DL, Rooney JF, Haas DW, Mellors JW, Havlir DV; AIDS Clinical Trials Group ..., AIDS, 1/1/2009
• Class-sparing regimens for initial treatment of HIV-1 infection  
  Riddler SA, Haubrich R, DiRienzo AG, Peeples L, Powderly WG, Klingman KL, Garren KW, George T, Rooney JF, Brizz B, Lalloo UG, Murphy RL, Swindells S, Havlir D, Mellors..., N Engl J Med, 1/1/2008
• Pulmonary mycobacterium avium complex following immune-reconstitution after HAART therapy  
  Ofotokun I, Busch K, Lee Y, Hoven A, Infect Dis Clin Pract, 1/1/2004
• Drug Costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital  
  Rapp, R.P., Evans, M.E., Martin, C., Ofotokun, I., Empey, K.L., and Armistead, J.A., Curr Med Res Opinion, 1/1/2004
• Reply to: Thrombosis, vasculitis, and cytomegalovirus infection  
  Markovitz DM, Gitlin SD, Ofotokun I, Clin Infect Dis, 1/1/2002
• Join now to see all

Books/Book Chapters

• Contraception for the Medically Challenging Patient 
  Chapter: Contraception for women living with HIV. 
  Haddad L, Tarleton J, Sheth AN, Ofotokkun ISpringer, New York, NY2014
• Sex Differences in Metabolism and Pharmacokinetics. 
  Sheth AN, Delille C, Ofotokun ISpringer, New York, NY2014
• The hope factor: Engaging the Church in the HIV/AIDS crisis. 
  Chapter: The emerging acquired immunodeficiency syndrome (AIDS) catastrophe in Nigeria. 
  Ofotokun IEditors: T. Yamamori, D. Dageforde, T. Bruner.Authentic Media2003

Abstracts/Posters

• The female genital tract microbiome is associated with vaginal antiretroviral drug concentrations in HIV-infected women on antiretroviral therapy.
  Donahue Carlson R, Sheth AN, Read T, Frisch M, Mehta C, Martin A, Evans-Strickfaden T, Haaland RE, Pau C, Kraft C, Hart CE, Ofotokun I, 21st International AIDS Conference, Durban, South Africa, 1/18/2016
• Trends and predictors of pregnancy and abortion rates among HIV infected and uninfected women enrolled in Women’s Interagency HIV study (WIHS): 1994-2012.
  Haddad LB, Wall K, C. Christina Mehta CC, Elizabeth Golub E, Rahangdale L, Kempf M, Karim R, Wright R, Minkoff H, Cohen M, Kassaye S, Cohan D, Ofotokun I, Cohn SE, 21st International AIDS Conference, Durban, South Africa, 1/18/2016
• Contribution of T cells to RANKL/OPG imbalance and bone loss in HIV infection.
  Titanji K, Vunnava A, Sheth AN, Lahiri CD, Lennox JL, Foster A, Weitzmann MN, Ofotokun I, 21st International AIDS Conference, Durban, South Africa, 1/18/2016
• Measurement of Abdominal Fat Changes in HIV-Infected Individuals Initiating Therapy.
  Bhagwat P, Ofotokun I, McComsey GA, Brown TT, Moser CB, Ribaudo HJ, Sugar CA, Currier JS, Conference of Retroviruses and Opportunistic Infections, Boston, MA, 1/1/2016
• Immunologic Effects of Maraviroc vs Tenofovir and Associations With Bone Loss.
  Chan ES, Mirmonsef P, Brown TT, Landay AL, Ofotokun I, Weitzmann MN, Martinson J, Plants J, Ribaudo HJ, Taiwo B, Conference of Retroviruses and Opportunistic Infections, Boston, MA, 1/1/2016
• A Single Dose Zoledronic Acid Prevents Antiretroviral-Induced Bone Loss.
  Ofotokun I, Titanji K, Vunnava V, Foster A, Sheth AN, Lahiri CD, Lennox JL, Knezevic A, Easley KA, Weitzmann MN, Conference of Retroviruses and Opportunistic Infections, Boston, MA, 1/1/2016
• Gender and Racial Disparities in Initial Antiretroviral Treatment Outcome: ACTG A5257.
  Ribaudo HJ, Landovitz RJ, Na LH, Lennox JL, Ofotokun I, Cohn SE, Kuritzkes D, Currier JS for the ACTG A5257 Study Team, Conference of Retroviruses and Opportunistic Infections, Boston, MA, 1/1/2016
• Perception of Infectiousness in HIV-Infected Persons After Initiating ART: ACTG A5257.
  Landovitz JL, Tran TT, Cohn SE, Ofotokun I, Bishopric GA, Lennox JL, Currier JS, Ribaudo JJ, Conference of Retroviruses and Opportunistic Infections, Boston, MA, 1/1/2016
• Lopinavir Use and Human Papillomavirus (HPV) Infection in HIV Positive Women.
  Delille CA, Burk RD, Palefsky JM, Massad LS, Reimers L, Minkoff H, Xie X, D’Souza G, Xue X, Colie C, Anastos K, Dugan KB, Wingood G, Strickler HD, Ofotokun I, Southern Regional Meetings, New Orleans, LA, 1/26/2015
• Progesterone Increases are Associated With HIV Susceptibility Factors in Women.
  Swaims A; Evans-Strickfaden T; Lupo LD; Aguirre A; Sheth S; Ofotokun I; Hart C; Haaland R, 22nd Conference of Retroviruses and Opportunistic Infections, Seattle, WA, 1/1/2015
• UGT1A1 Genotype Predicts Bilirubin-related Discontinuation of Atazanavir/Ritonavir.
  Vardhanabhuti S, Ribaudo H, Raphael Landovitz R, Ofotokun I, Lennox J, Currier J, Olson L, Haas D, 22nd Conference of Retroviruses and Opportunistic Infections, Seattle, WA, 1/1/2015
• Lopinavir Use and Human Papillomavirus (HPV) Infection in HIV Positive Women.
  Delille CA, Burk RD, Palefsky JM, Massad LS, Reimers L, Minkoff H, Xie X, D'Souza G, Xue X, Colie C, Anastos K, Dugan KB, Wingood G, Strickler HD, Ofotokun I, 29th International Papillomavirus Conference, Seattle, WA, 1/21/2014
• The prevalence of persistent low-level viremia and virologic failure among a cohort of HIV-infected women on antiretroviral therapy.
  Aguirre AJ, Mehta C, Ofotokun I, Gandhi M, Hussen SA, Merenstein D, Kashuba AD, Anastos K, Kempf MC, Golub ET, Greenblatt RM, Dehovitz JA, Milam J1, Cohen MH1, Sheth, CFAR Symposium on HIV Research in Women, Buffalo, NY, 1/8/2014
• Darunavir or atazanavir versus raltegravir lipid changes are unlinked to ritonavir exposure: ACTG 5257.
  Ofotokun I, Ribaudo H, Na L, McComsey G, Cohn S, Godfrey C, Sagar M, Aweeka F, Lennox J, Currier J, 21st Conference of Retroviruses and Opportunistic Infections, Boston, MA, 1/3/2014
• Efficacy and tolerability of atazanavir, raltegravir, or darunavir with FTC/tenofovir.
  Landovitz RJ, Ribaudo HJ, Ofotokun I, Wang H, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS, and Lennox JL and the A5257 Study Team, 21st Conference of Retroviruses and Opportunistic Infections, Boston, MA, 1/3/2014
• Population analysis of tenofovir plasma and intracellular pharmacokinetics in female HIV-1 seropositive patients.
  Larson KB, Wang K, James AM, Otofokun I, Sheth A, Delille C, Vunnava A, Acosta EP, 15th Antiretroviral PK Workshop, Washington, DC, 1/1/2014
• Lopinavir Use and Human Papillomavirus (HPV) Infection in HIV Positive Women.
  Delille CA, Dugan KB, Burk RD, Palefsky JM, Massad LS, Reimers L, Minkoff H, Xie X, D’Souza G, Xue X, Colie C, Anastos K, Wingood G, Strickler HD, Ofotokun I, Department of Medicine Research Day, Emory University, Atlanta, GA, 1/1/2014
• Degree of Plasma Protein Binding Affects Central Nervous System (CNS) Penetration of the HIV-1 Protease Inhibitors.
  Delille CA, Pruett ST, Marconi VC, Armstrong WS, Lennox JL, Arrendale RF, Sheth AN, Easley KA, and Ofotokun I, 2nd Annual NIAID/IDSA Research Careers Meeting, Bethesda, MD, 1/6/2013
• Integrated Model of Lopinavir Pharmacokinetics and HIV-1 Viral Dynamics: The Role of beta-1-acid Glycoprotein Binding.
  Wang K, D’Argenio D, Sheth A, Lennox JL, Acosta EP, and Ofotokun I, ACoP, Fort Lauderdale, FL, 1/1/2013
• Integrated population pharmacokinetic and viral dynamic modeling of lopinavir/ritonavir in HIV-1 treatment naïve patients.
  Wang K, D’Argenio DZ, Acosta EP, Sheth AN, Delille C, Lennox JL, Kerstner-wood C, and Ofotokun I, 4th International Symposium in Quantitative Pharmacology, Beijing, China, 1/1/2013
• Improving Tuberculosis Screening and Isoniazid Preventative Therapy in an HIV Clinic in Addis Ababa, Ethiopia.
  Zaeh S, Kempker R, Stenehjem E, Blumberg HM, Ofotokun I, Tenna A, 20th Conference of Retroviruses and Opportunistic Infections, Atlanta, GA, 1/1/2013
• B Cell Dysregulation Promotes HIV-induced Bone Loss.
  Titanji K, Vunnava A, Sheth A, Lennox J, Weitzmann MN, Ofotokun I, 20th Conference of Retroviruses and Opportunistic Infections, Atlanta, GA, 1/1/2013
• Improving Tuberculosis Screening and Isoniazid Preventative Therapy in an HIV Clinic in Addis Ababa, Ethiopia.
  Zaeh S, Kempker R, Stenehjem E, Blumberg HM, Ofotokun I, Tenna A, Medical Students Research Day, Emory University, Atlanta, GA, 1/1/2013
• Improving Tuberculosis Screening and Isoniazid Preventative Therapy in an HIV Clinic in Addis Ababa, Ethiopia.
  Zaeh S, Kempker R, Stenehjem E, Blumberg HM, Ofotokun I, Tenna A, Southern Regional Meetings, New Orleans, LA, 1/1/2013
• Degree of Plasma Protein Binding Affects Central Nervous System (CNS) Penetration of the HIV-1 Protease Inhibitors.
  Delille CA, Pruett ST, Marconi VC, Armstrong WS, Lennox JL, Arrendale RF, Sheth AN, Easley kA, and Ofotokun I, Department of Medicine Research Day, Emory University, Atlanta, GA, 1/1/2013
• Join now to see all

Lectures

• Chronic HIV infection and end-organ Health 
  NIH, Bethesda, MD - 1/17/2016
• Immune dysregulation – a driving force behind HIV associated bone loss. 
  University of North Carolina - 1/1/2016
• Updates in HIV disease management 
  Orlando, FL - 1/1/2014
• Translation approach towards understanding the impact of HIV-infection in women. 
  Atlanta, GA - 1/1/2014
• Pharmacodynamics approaches – Women Interagency HIV Study 
  Bethesda, MD - 1/1/2014
• Multicenter AIDS Cohort Study 
  Bethesda, MD - 1/1/2014
• K-club - Transition from K-award to independence in research 
  Emory University, Atlanta, GA - 1/1/2014
• Individualized HIV Treatment Strategy 
  New Orleans, LA - 1/1/2014
• Ebola virus disease 
  Abuja, Nigeria - 1/1/2014
• HIV Reservoir in women – novel Pharmacokinetics 
  Bethesda, MD - 1/1/2014
• Translational Approach Towards Understanding the Long Term Complications of HIV Infection. 
  Bethesda, MD - 1/1/2013
• Translational approach towards understanding long-term complications of HIV diseases management 
  Atlanta, GA - 1/1/2013
• Finding and keeping a mentor. 
  Bethesda, MD - 1/1/2013
• Updates – HIV and antiretroviral induced bone loss 
  Atlanta VA Medical Center, Atlanta, GA - 1/1/2013
• CONSORT and other publishing guidelines 
  1/1/2013
• Critical Review of the Medical Literature 
  University of Kentucky - 1/1/2013
• Translational approach towards understanding the long term complications of HIV infection with emphasis on the skeletal system 
  Atlanta VA Medical Center, Atlanta, GA - 1/1/2012
• HIV and Bone Disease 
  Puebla, Mexico - 1/1/2011
• Pathogenesis of HIV-induced Bone Loss 
  Drexel University, Philadelphia, PA - 1/1/2011
• Medical School Curriculum: Integration of Basic and Medical Sciences 
  Abuja, Nigeria - 1/1/2011
• Long-Term Complication of HIV-disease Management: The Bone. 
  Emory University, Atlanta, GA - 1/1/2011
• K-award to R01 Conversion 
  Emory University, Atlanta, GA - 1/1/2011
• HIV Pharmacotherapy update 
  University of Alabama, Birmingham, AL - 1/1/2010
• Emerging Challenges in HIV Pharmacotherapy 
  Atlanta, GA - 1/1/2010
• Long-Term Complications of HIV-disease Management: The Bone. 
  Atlanta, GA - 1/1/2010
• Join now to see all

Other

• 2002-2003 Empiric Antimicrobial Therapy Manual 
  Ofotokun I
  University of Kentucky Medical Center